To determine whether the loss of RRM1 affects global cancer metabolism, we performed metabolome analysis using the ω-Scan package from Human Metabolome Technologies (HMT) Inc. (Tsuruoka, Yamagata, Japan) and a capillary electrophoresis Orbitrap mass spectrometer (CE-FTMS), as described previously35–38. This evidence concerns the gene RRM1 and cancer.